Q3 FY2026 · ended Sep 30, 2026 · Revenue $221.59M, +14.9% YoY · Filed Nov 5, 2026
iRhythm Holdings, Inc. (IRTC) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $221.6 million and a net loss of $29.9 million. Free cash flow was -$11.5 million. As of Sep 30, 2026 it held $635.2 million in cash and investments and $73.9 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- IRTC (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1388658
- Former names
- IRhythm Technologies, Inc. (until Jan 12, 2026); iRhythm Technologies, Inc. (until Jan 12, 2026); IRhythm Technologies Inc (until May 18, 2010)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $221.6M | $224.2M | $199.4M | $208.9M | $192.9M |
| Operating income | -$32.6M | -$2.5M | -$16.2M | $2.3M | -$8.4M |
| Net income | -$29.9M | -$381,000 | -$13.9M | $5.6M | -$5.2M |
| Diluted EPS | -$0.90 | -$0.01 | -$0.43 | $0.17 | -$0.16 |
| Operating cash flow | $4.4M | $51.1M | -$26.2M | $26.2M | $34.9M |
| Free cash flow | -$11.5M | $37.5M | -$33.1M | $14.5M | $20.1M |
| Total assets | $1.1B | $1.1B | $1.0B | $1.0B | $995.2M |
| Total liabilities | $914.3M | $907.4M | $845.2M | $867.3M | $873.3M |
| Stockholders' equity | $177.1M | $186.0M | $161.2M | $152.7M | $121.9M |
| Cash and investments | $635.2M | $665.0M | $622.5M | $653.7M | $633.3M |
| Total debt | $73.9M | $76.3M | $79.0M | $81.7M | $84.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 5, 2026 | Oct 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 13, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 6, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Jul 31, 2026 |
All 849 iRhythm Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.